• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Del Global stakes claim in European states

Article

Del Global Technologies signed a distribution agreement with the European Distribution Organization granting the EDO the right to act as the exclusive distributor of Del Global’s medical imaging systems.Countries in the EDO include Poland, the Czech

Del Global Technologies signed a distribution agreement with the European Distribution Organization granting the EDO the right to act as the exclusive distributor of Del Global’s medical imaging systems.

Countries in the EDO include Poland, the Czech Republic, the Slovak Republic, Hungary, Greece, Romania, Turkey, Bulgaria, Yugoslavia, Russia, and others in the Commonwealth of Independent States. Del Global president and CEO Leonard Trugman said he looks forward to the increased presence of his company in these countries.

Del Global obtained a 19% stake in Villa Sistemi in January, along with the nonrevocable option to increase its ownership share to 80%, and it decided to exercise that option in April (SCAN 5/10/00). This month, the FDA gave its approval for Del Global to market Villa Sistemi’s Vision tilting table for radiographic and fluoroscopic examinations.

Del Global is a Valhalla, NY-based designer, developer, and manufacturer of medical and dental imaging systems. Villa Sistemi is based in Milan, Italy (SCAN 6/21/00).

Recent Videos
Can an Emerging AI Software for DBT Help Reduce Disparities in Breast Cancer Screening?
Skeletal Muscle Loss and Dementia: What Emerging MRI Research Reveals
Magnetoencephalopathy Study Suggests Link Between Concussions and Slower Aperiodic Activity in Adolescent Football Players
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Can 18F-Floutufolastat Bolster Detection of PCa Recurrence in Patients with Low PSA Levels After Radical Prostatectomy?
2 KOLs are featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.